Abstract:Alcoholic liver disease (ALD) is one of the severe liver diseases, resulting in high morbidity and mortality. However, frataxin, a mitochondrial protein mainly participating in iron homeostasis and oxidative stress, remains uncertain in the pathogenesis of ALD. In the present study, the role of frataxin in ALD was investigated. Ethanol (100 mM) decreased frataxin expression at 48 and 72 h in HepG2. Dramatically, in HepG2 overexpressing cytochrome P450 2E1 (HepG2CYP2E1+/+), frataxin level was down-regulated with ethanol stimulation at 12 h. Moreover, chronically feeding ethanol to mice via Lieber-DeCarli liquid diet (30% of total calories) for 15 weeks significantly inhibited frataxin expression. Ferroptosis signature proteins were dysregulated, accompanied by mitochondria morphological damage, enhanced malondialdehyde and decreased glutathione in the liver, as well as accumulation of reactive oxygen species and mitochondrial labile iron pool in primary hepatocytes. Notably, proteomics screening of frataxin deficient-HepG2 further suggested frataxin was associated with ferroptosis. Furthermore, the ferroptosis inhibitor ferrostatin-1 blocked the increase of lactate dehydrogenase release by ethanol in HepG2CYP2E1+/+. Most importantly, frataxin deficiency enhanced ferroptosis driven by ethanol via evaluating the levels of lactate dehydrogenase, cell morphological changes, mitochondrial labile iron pool, and lipid peroxidation. Conversely, restoring frataxin alleviated the sensitivity to ferroptosis. In addition, frataxin overexpression mitigated the sensitivity of ethanol-induced ferroptosis in HepG2CYP2E1+/+. Collectively, our study revealed that frataxin-mediated ferroptosis contributed to ALD, highlighting a potential therapeutic strategy for ALD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how ethanol mediates alcoholic hepatocyte toxicity by oxidant - stress - dependent inhibition of frataxin expression, and then leads to alcoholic liver disease (ALD) through the ferroptosis mechanism. Specifically, the study focuses on the following points: 1. **Effect of ethanol on frataxin expression**: The researchers observed that ethanol can inhibit frataxin expression both in vitro (HepG2 cells) and in vivo (mouse liver), and this inhibition is partly dependent on oxidative stress. 2. **Relationship between frataxin and ferroptosis**: Through proteomic analysis, the study found that frataxin deficiency is related to ferroptosis. In the livers of frataxin - deficient mice, the expressions of ferroptosis - marker proteins (such as GPX4 and xCT) change, accompanied by an increase in lipid peroxidation and mitochondrial iron pool. 3. **Effect of frataxin deficiency on the sensitivity to ethanol - induced ferroptosis**: The study shows that frataxin deficiency significantly enhances ethanol - induced ferroptosis, manifested as an increase in lactate dehydrogenase (LDH) release, cell morphology changes, an increase in mitochondrial iron pool and lipid peroxidation accumulation. 4. **Protective effect of restoring frataxin expression**: Restoring frataxin expression by adenovirus - mediated gene transfer can alleviate ethanol - induced ferroptosis, reduce LDH release, and decrease mitochondrial iron pool and lipid peroxidation accumulation. 5. **Frataxin inhibition may mediate alcoholic hepatocyte toxicity through other cell death pathways**: Besides ferroptosis, the study also explored whether frataxin inhibition mediates alcoholic hepatocyte toxicity through other cell death pathways such as apoptosis, autophagy or necrosis. In summary, this paper aims to reveal the mechanism of frataxin in alcoholic liver disease, especially its hepatocyte toxicity mediated by the ferroptosis pathway, and provide new potential strategies for the prevention and treatment of alcoholic liver disease.

Oxidative stress-dependent frataxin inhibition mediated alcoholic hepatocytotoxicity through ferroptosis